Xanamem

DRUG2 trials

Sponsors

Actinogen Medical

Conditions

Alzheimer DiseaseCentral Nervous SystemCerebrospinal FluidCognitive FunctionCortisolDementia ModerateDementia, MildElectrocardiography

Phase 1

Xanamem™ in Healthy Elderly Subjects

CompletedNCT03830762

Actinogen MedicalCentral Nervous System, Cerebrospinal Fluid, Cognitive Function +6

Start: 2019-01-21End: 2020-01-07Updated: 2025-01-22

Phase 2

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Active, not recruitingNCT06125951

Actinogen MedicalAlzheimer Disease, Dementia, Mild, Dementia Moderate

Start: 2024-04-12End: 2028-02-01Updated: 2026-07-21